Bayer Offers New Antibiotic With Promise in Fight on TB

In an unusual step, Bayer Healthcare announced yesterday that it had agreed to allow its most promising new antibiotic, moxifloxacin, be tested against tuberculosis, a disease that kills 5,000 people a day and is the immediate cause of death for a third of the world's AIDS victims. If the antibiotic substantially shortens TB treatment, which now typically lasts six months, the company will make millions of doses and sell them at low prices to poor countries. Bayer's decision is unusual because major drug companies rarely test their best-selling patented antibiotics against diseases of the poor - and virtually never test them against tuberculosis - for fear of hurting sales in rich countries. Bayer makes about $500 million a year from moxifloxacin, which it sells in the United States as Avelox and elsewhere as Avalox, Avelon, Megaxin, Actira and Izilox.

1 comment:

Nosey said...

Hi nice blog I am blog surfing and foun you I want to spread the word about the bird flu virus people will need to get immunised ebay have stopped people selling anti flu stuff on their website .. try they have less restrictions and are new so maybe people will sell from theregoogle tamiflu

Blog Archive